Valeant Pharmaceuticals Intl Inc (NYSE:VRX)
On Tuesday, Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s shares declined -4.05% to $70.35.
VRX offered 66.80% EPS for prior five years. The company has 9.90% return on equity value while its ROI ratio was 8.40%. The company has $25.15 billion market capitalizations and the institutional ownership was 66.80%. Its price to book ratio was 3.82. Volatility of the stock was 6.09% for the week while for the month booked as 13.74%.
Analysts mean recommendation for the stock is 3.00. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Valeant Pharmaceuticals International, Inc. is a specialty pharmaceutical and medical device company. The Company is engaged in developing, manufacturing, and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses.
Rite Aid Corporation (NYSE:RAD)
Rite Aid Corporation (NYSE:RAD)’s shares dropped -0.39% to $7.72.
RAD has beta value of 1.88. The company has the market capitalization of $8.07 billion. Return on assets ratio of the company was 20.50% while its return on equity ratio was -686.80%. ATR value of company was 0.24 while stock volatility for week was 1.76% while for month was 4.12%. Debt to equity ratio of the company was 17.32 and its current ratio was 1.50.
The mean estimate for the short term price target for Rite Aid Corporation (NYSE:RAD) stands at $9.50 according to 11 Analysts. The higher price target estimate for the stock has been calculated at $10.00 while the lower price target estimate is at $8.50.
Analysts mean recommendation for the stock is 2.20. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Rite Aid Corporation is a retail drugstore chain. The Company sells prescription drugs and a range of other merchandise, which are referred to as front-end products. The Company’s drugstores’ primary business is pharmacy services.
Turquoise Hill Resources Ltd (NYSE:TRQ)
At the end of Tuesday’s trade, Turquoise Hill Resources Ltd (NYSE:TRQ)‘s shares dipped -4.01% to $2.63.
TRQ has market value of $5.48 billion while its EPS was booked as $0.13 in the last 12 months. The stock has 2.01 billion shares outstanding while 38.50% shares of the company were owned by institutional investors. In the profitability analysis, the company has gross profit margin of 39.90% while net profit margin was 13.30%. Beta value of the company was 1.48; beta is used to measure riskiness of the security.
The mean estimate for the short term price target for Turquoise Hill Resources Ltd (NYSE:TRQ) stands at $4.94 according to 1 Analysts. The higher price target estimate for the stock has been calculated at $4.94 while the lower price target estimate is at $4.94.
Analysts mean recommendation for the stock is 2.50. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Turquoise Hill Resources Ltd. (Turquoise Hill) is an international mining company focused on mining operations in Mongolia. The Company’s principal and only material mineral resource property is the Oyu Tolgoi copper-gold mine in southern Mongolia.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.